Agoracom Blog Home

Posts Tagged ‘$TSXV’

CLIENT FEATURE: Explor Resources (EXS: TSX-V) 609K oz Indicated / 470K oz Inferred Gold $EXS.ca

Posted by AGORACOM-JC at 12:43 PM on Monday, February 27th, 2017

Why Explor Resources?

  • Flagship Property Offers The Following:
  • NI 43-101 Resource – 609,000 oz Indicated / 470,000 Inferred
  • Teck Resources To Spend $12 MILLION To Earn 70%
  • Property Is 13 KM From Downtown Timmins
  • 2nd Project 43-101 Open Pit Resource
  • 1.4 MILLION T Indicated @ 1.38% Copper
  • 2.09 MILLION T Inferred @ 1.26% Copper

ONTARIO AND NEW BRUNSWICK PROPERTIES CURRENTLY UNDER EXPLORATION

Timmins Porcupine West (TPW) (4300 ha)

  • NI 43-101 Resource: 609,000 oz Indicated
    470,000 oz Inferred Gold
  • 13 km from downtown Timmins
  • Property is 2.5 km, NE of LSG West Timmins Mine
  • Model: Hollinger McIntyre Gold System: 30,000,000 oz. Au
  • Discovery Hole 10-30 : 9.22g/tonne over 11.0 meters
  • Optioned to Teck Resources
  • Teck to spend $12,000,000 to earn 70% interest

Chester Copper & VMS Project (3500ha)

  • Recent intersection of 2.187% Copper Over 9.66 Meters
  • Mineral Target: Cu, Pb, Zn, Ag, & Au
  • 70 km SW of Bathurst NB
  • Structural Model Complete
  • 300 m wide x 2000m long mineralized Corridor identified
  • Ramp to ore zone (480 meter long (3m x 4m)
  • Optioned to Brunswick Resources (BRU)
  • Brunswick to spend $500,000 over 3 years
  • Explore to receive $40,000 and 5,000,000 shares of BRU
  • Open pit resource – NI 43-101 Resource: 1,400,000 Indicated t @ 1.38% Cu
    2,089,000 Inferred t @ 1.26 % Cu
  • Recently completed diamond drill Holes for a total of 2,027 meters


Kidd Creek Project (2466 ha)

  • Mineral Target: Cu-Zn Ore
  • Located 1.0 km west of Kidd Creek Mine
  • Kidd Mine yielded 130M tonnes of Cu-Zn Ore since 1960
  • Numerous Geophysical max/min and IP Targets
  • So encouraged by the initial results of the 3000 meter program, decided to more than double the diamond drilling program planned to 7275.7 meters

QUEBEC PROPERTIES CURRENTLY UNDER EXPLORATION

East Bay (3203 ha):

  • Mineral Target: Gold
  • Lies on Porcupine Destor Fault Zone, on strike with Beattie & Donchester mine
  • Historical channel samples by Lacana Mining in 1982 including: 0.81 oz/ton over 5ft; 0.16 oz/ton over 6 ft; 0.10 oz/ton over 10 ft
  • Wrap around Clifton Star

Nelligan (1198 ha):

  • Mineral Target: Nickel
  • Located in Val d’Or mining district of Quebec
  • Historical grab samples of 10% Ni and 0.6% Cu obtained by INCO
  • Discovered anomalous Nickel, Copper Zones

Launay (2250 ha):

  • Mineral Target: Nickel
  • Mineralized zones contained in mafic volcanic rocks
  • Contiguous to Royal Nickel’s Dumont property (NW end)

12 Month Stock Chart

Expand uses for medical marijuana $MCOA.us $TBP.ca

Posted by AGORACOM-JC at 10:17 AM on Monday, February 27th, 2017
  • New Jerseyans with chronic pain can receive the kind of relief from medicinal marijuana they cannot get from any other drug
  • In many cases pot does a better job reducing the pain, and without unwanted side effects.
  • Limiting its benefits because of outdated notions about the dangers of marijuana use is misguided
On Wednesday advocates for expanding eligible conditions under New Jersey’s medical marijuana program will have their first formal chance to make their case before a special panel created to consider such pleas.

Loosening some of the reins on medical marijuana is long overdue, and we urge panel members to enter the process with an open mind and a willingness to broaden the potential to bring relief to those in pain.

If they do, it will mark a significant contrast to most anything we’ve seen from Gov. Chris Christie’s administration, which has been reluctant to implement the program from the start and has thrown up repeated obstacles that have effectively limited distribution.

Christie inherited the program from former Gov. Jon Corzine, who legalized medical marijuana but left office before any of the particulars of the new law had been put in place. That left Christie — an opponent of legalization — to oversee the details, providing ample opportunity for delay while establishing new regulations.

There was little point to the foot-dragging other than to burnish Christie’s conservative credentials in opposing any form of pot legalization. The governor continues to cling to the widely discredited argument of marijuana as a gateway drug leading to more addictive and more lethal substances. The end result was to deny relief to patients experiencing chronic pain from certain medical conditions, relief that should have been available to them under the law, except for the implementation delays.

Even now, however, patient advocates say New Jersey’s medical marijuana program is needlessly restrictive, failing to include many health issues that should be covered by the law. That’s what Wednesday’s meeting of the Medicinal Marijuana Review Panel could help correct. The hearing is an outgrowth of a 2014 lawsuit that challenged the unacceptably long implementation process.

In July the state health department sought written requests for illnesses to be added to the eligibility list, and among those offered were conditions generating chronic pain such as osteoarthritis and Lyme disease. In September Christie surprised many by making medical marijuana available to post-traumatic stress disorder sufferers, the first new condition added under the law.

The review panel should follow that lead, even if Christie would rather it not. We’ve come a long way in our understanding of the pros and cons of marijuana use for medicinal purpose. Public support to broaden legalization continues to grow across the nation. We continue to oppose it in New Jersey, although attempts to legalize it here are sure to intensify once Christie leaves office.

In the meantime, however, many New Jerseyans with chronic pain can receive the kind of relief from medicinal marijuana they cannot get from any other drug. In many cases pot does a better job reducing the pain, and without unwanted side effects. Limiting its benefits because of outdated notions about the dangers of marijuana use is misguided.

The hearing will begin at 10 a.m. Wednesday in Trenton, at the War Memorial, Turning Point Conference Room at 1 Memorial Drive.

Source: http://www.app.com/story/opinion/editorials/2017/02/21/medical-marijuana-new-jersey-health-conditions/98212062/

Durango Receives Additional Offer On Windfall Gold Camp Property $DGO.ca

Posted by AGORACOM-JC at 8:40 AM on Monday, February 27th, 2017

Logo

  • Additional unsolicited offer was received on its Trove Property located in the Windfall-Urban gold camp district of northern Quebec

Vancouver, BC / February 27, 2017 – Durango Resources Inc. (TSX.V-DGO), (the “Company” or “Durango”) announces that further to the news of February 24, 2017, an additional unsolicited offer was received on its Trove Property located in the Windfall-Urban gold camp district of northern Quebec.

Durango’s 100% wholly owned Trove Property adjoins Osisko Mining (TSX-OSK) and Beaufield Resources (TSX.V-BFD) who both hold large land packages in the area and currently have drill programs underway.

Marcy Kiesman, CEO of Durango stated “Three companies in the Windfall Lake area have raised over $70 million dollars this month for exploration. As two of Durango’s immediate neighbours are drilling over 400,000 metres at Windfall, the Trove Property remains positioned for discovery. Durango’s Board of Directors is reviewing the offers for the Trove Property, however no agreements have been reached, and the Company will provide further details as they become available.”


Click Image To View Full Size

About Durango

Durango is a natural resources company engaged in the acquisition and exploration of mineral properties. The Company has a 100% interest in the Mayner’s Fortune and Smith Island limestone properties in northwest British Columbia, the Decouverte and Trove gold properties in the Abitibi Region of Quebec, and certain lithium properties near the Whabouchi mine, the Buckshot graphite property near the Miller Mine in Quebec, the Dianna Lake silver project in northern Saskatchewan, the Whitney Northwest property near the Lake Shore Gold and Goldcorp joint venture in Ontario, as well as three sets of claims in the Labrador nickel corridor.

For further information on Durango, please refer to its SEDAR profile at www.sedar.com.

Marcy Kiesman, Chief Executive Officer

Telephone: 604.428.2900 or 604.339.2243

Facsimile: 888.266.3983

Email: durangoresourcesinc@gmail.com

Website: www.durangoresourcesinc.com

Forward-Looking Statements

This document may contain or refer to forward-looking information based on current expectations, including, but not limited to the completion of any transaction involving the Trove Property with any third party and the impact on the Company of these events. Forward-looking information is subject to significant risks and uncertainties, as actual results may differ materially from forecasted results. Forward-looking information is provided as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances. For a detailed list of risks and uncertainties relating to Durango, please refer to the Company’s prospectus filed on its SEDAR profile at www.sedar.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

MUST READ WEEKEND FEATURE: New Age Dawns for Palladium $NAM.ca

Posted by AGORACOM-JC at 3:54 PM on Friday, February 24th, 2017

 

Primary PGM deposits are rather rare beasts in North America (indeed everywhere outside Russia and South Africa), the River Valley project of New Age Metals deserves special attention as PGMs are likely to become a subject of much interest in the next few years and the alternatives in terms of developers are few and far between

| February 22, 2017 |

While Lithium sets the pulse racing of some investors, in the case of New Age Metals Inc. (TSXV: NAM | OTCQB: PAWED) it is its PGM potential that is the standout feature. And of that, we particularly like that its Pd to Pt ratio is 2.5:1 as we are much more disposed to Palladium than Platinum at this time. As primary PGM deposits are rather rare beasts in North America (indeed everywhere outside Russia and South Africa), the River Valley project of New Age Metals deserves special attention as PGMs are likely to become a subject of much interest in the next few years and the alternatives in terms of developers are few and far between. In this article we shall look at what makes New Age Metals interesting.

Palladium – Back on a Tear

This metal may be Platinum’s less precious sister but it has been attracting more of the limelight in recent months. Despite substantial sell-offs from the South African-based ETFs (which was hoovered up by China apparently) the metal just kept bouncing back and as the chart below shows is heading into territory that represents multi-year highs. Indeed the last time it was at these levels was in early 2015.

The increase is said to be attributable not only to a noticeable drop in production of platinum group metals in South Africa in November, but also to an extension of tax breaks for car buyers in China. However some market pundits have claimed that the tax breaks in China are not a sufficient factor to explain the moves. All attempts at propagating bad news about the metal tends to just precede a rebound.

As long as auto sales continue around about their recent healthy levels then the prospect is for palladium (and platinum) to continue their gradual rise.

New Age and PGMs

The company’s River valley project is located in a road-accessible location in the Dana and Pardo townships of Northern Ontario, approximately 60km east of Sudbury, Ontario. The area is part of Canada’s prime Ni-Cu-PGM mining and smelting district with excellent infrastructure and community support for mining activities.

The River Valley PGM project became a target for Pacific North West Capital (PFN) in 1998. PFN discovered significant PGM occurrences on the property and entered into a joint venture agreement with Anglo Platinum in 1999. PFN was the operator of the joint venture. The project consists of two Mining leases covering an area of 5,381 hectares, including 4,756 hectares of Surface and Mining Rights and an additional 624 hectares of Mining Rights. These Mining Leases cover all of the NI43-101 mineral resources of the River Valley PGM Project. In January 2011, the company completed the terms for the acquisition of 100% of the project from Anglo Platinum Limited. The property remains subject to a 3% NSR, with options to buy down.

Geology

The River Valley intrusion (RVI) is shallow-dipping, layered, and approximately 900 m thick. There is an increase in metamorphic grade from the northwest part of the intrusion (middle greenschist facies) to the southeast part (lower amphibolite). The dominant rock types are leucogabbronorite and leucogabbro with gabbros and anorthosites . Along the Grenville Front, the RVI is either in thrust contact with quartzite of the Huronian Mississagi Formation or is in contact with mafic and felsic metavolcanic rocks of the lower Huronian Supergroup where the nature of the contact is unknown.

The map below shows the concession and in dark red can be seen the main identified areas of PGM mineralisation.

Two styles of mineralization have been observed at the Project; contact nickel-PGE and reef PGE mineralization. In the resource estimate Tetratech note that the presence of several highly anomalous assays from rocks lying within higher portions of the River Valley Intrusion’s stratigraphy (i.e. Azen Creek Wonder Showing) suggests that there are opportunities for PGE mineralization such as reef or stratabound-type targets or, narrow, high-grade breccia zones. The image below shows an axonometric view of the Dana South and Dana North and Banshee segments of the deposit (which are located at the northern end thereof).

Exploration

The exploration history of the region dated back to the 1960s, with work on the property starting in earnest in 1999. Completed exploration and development programs on the River Valley property include more than 600 holes drilled since 2000 and several mineral resource estimates and metallurgical studies.

The 2015 drill program confirmed the new high-grade T2 discovery. Drill hole intercepts were much higher than the average grade of current mineral resource estimate. There is the possibility of a new mineralized zone at the north end of the River Valley deposit.

In 2015-16 seven drill holes at Pine Zone intersected high-grade PGM mineralization of:

  • Hole 2015-DN002 intersected 9 m grading 3.909 g/t Pd+Pt from 145 m downhole
  • Hole 2015-DN001 intersected 16 m grading 2.054 g/t Pd+Pt from 184 m downhole
  • Hole 2016-DN-T2-06 intersected 9 m grading 4.065 g/t Pd+Pt from 178 m downhole
  • Hole 2016-DN-T2-10 intersected 4m grading 3.093 g/t Pd+Pt from 202 m downhole

Resource

The most recent resource estimate dates from  May 2012 and were prepared by Tetratech. The estimate utilized a Cut-Off Grade of 0.8 g/t PdEq.

The results of which were:

Of which the contained “precious” metals were:

There are also showings of copper, nickel and silver but really this project will stand or fall on its PGM content and from the resource it is clear that these are starting to stack up as meaningful indeed.

Results for the most recent Metallurgical Testwork Study (prepared by Tetra Tech – Wardrop) are summarized below:

  • High Confidence: Measured plus Indicated = 72% of total
  • High Grade potential, particularly in the north part of River Valley deposit
  • Resources under evaluation for development potential as open pit mining operation

Adding to the Patch

In August 2016 PFN acquired what it calls the River Valley Extension Project (to the southeast of the existing claims) from Mustang Minerals Corp. With this transaction the area of the strategic land position at River Valley increased to 64 km2 (15,800 acres). More importantly the strike length of River Valley deposit increased from 12 km to 16 km. Not much work has been done as yet but surface grab samples returned assays of up to 10 g/t  of PGMs.

Next Steps

The plan for 2017 is to undertake:

  • Three-dimensional Geological and Structural Modelling
  • IP geophysical surveys over the new Pine Zone
  • Phase 3 Drilling of Pine Zone
  • Develop additionalstructural PGM targets for priority drill testing
  • Design Phase 4 Drill Plan

This work has a rather unchallenging provisional budget of around CAD$1mn.

As far as a mine plan is concerned that company plans to take the roughly 600,000 ounces it has in the Northern Portion of the Project up to one million ounces and then wrap a PEA around that.

  • Delineation and infill drilling of Pine Zone
  • Updated Mineral Resource Estimate
  • Phase 1 drill tests of other structural targets for higher grade mineralization (south from the Pine Zone in the area from T3 to T9)
  • Carry out Phase 2 metallurgical testwork

The timing for PEA (if all goes well) might be 12 to 15 months. This work has a provisional budget of a more challenging CAD$5mn.

Conclusion

The main priority for New Age now is its ongoing search for a strategic partner for the River Valley project. While the company has some secondary interests in Lithium, it’s more PGM projects that the market needs at this juncture. With the prices for this rarified group of metals showing a healthy rebound, those investors in search of the next companies to move towards production have little beyond New Age and Wellgreen to conjure with.

Considering that the recovery in PGM prices is now no longer in question we must wonder why the market seems to have missed the intrinsic virtues of the River Valley Project. We suspect it is more a case of the Canadian investor community still being in thrall to the gold price even when the gold price is quite patently not delivering in the way that PGMs are. When one overlays the industrial necessity for PGMs and the fact that the two largest producer nations are somewhat erratic there would appear to be space for the two challenger companies to join the two existing plays (North American Palladium and Stillwater, the latter being taken over by Sibanye) in the universe for consideration. At its current market capitalization New Age is patently undervalued on the basis of its sizeable in situ resource of PGMs.

With the resurgence of Palladium (and Platinum), a name change to a more pertinent designation (and a stock rollback) a New Age, to belabor the pun, should be dawning for this company.

Source: https://investorintel.com/sectors/gold-silver-base-metals/gold-precious-metals-intel/new-age-dawns-palladium/

Namaste to Acquire Australian Vaporizers and Announces $6.0 Million Bought Deal Financing $N.ca

Posted by AGORACOM-JC at 9:03 AM on Friday, February 24th, 2017

Nlogo

  • Entered into a definitive agreement with Australian Vaporizers PTY Limited to acquire all of the issued and outstanding shares of Australian Vaporizers in exchange for a combination of cash, common shares and an earn-out payment
  • Company’s website www.australianvaporizers.com.au has approximately 80% of the market share
  • For the period ended June 30, 2016, the company produced approximately $4.5 million of revenue and $1.1 million of EBITDA

VANCOUVER, BRITISH COLUMBIA–(Feb. 24, 2017) -

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES

Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N)(CSE:N.CN)(FRANKFURT:M5BQ) is pleased to report that it has entered into a definitive agreement (the “Agreement”) with Australian Vaporizers PTY Limited (“Australian Vaporizers”) to acquire all of the issued and outstanding shares of Australian Vaporizers in exchange for a combination of cash, common shares and an earn-out payment. Upon the completion of the transaction, Namaste further solidifies its position as the leading e-commerce company in the vaporizers and accessories space with significant market positions in the North America, Europe, South America and now Asia Pacific.

Australian Vaporizers was founded in 2010 and has grown to become the largest online retailer of vaporizers in Australia. The company’s website www.australianvaporizers.com.au has approximately 80% of the market share. The company’s customer database has over 48,000 individuals that have made upwards of 77,000 orders during the lifespan of the company. For the period ended June 30, 2016, the company produced approximately $4.5 million of revenue and $1.1 million of EBITDA. Gross margins for the period were over 45%. The financial results for the period have been audited by Grant Thornton Australia Ltd.

Strategic rationale for the transaction as follows:

  • Positions Namaste as the leading vaporizer and accessories company in Australia, a country with a population of 24.3 million people;
  • Expands customer database to well-over 300,000 individuals globally. This further positions the Company with one of the largest databases of cannabis consumers globally and spans all major markets. Namaste will enter commercial arrangements to further monetize these customers;
  • Positions the Company with over $18.0 million of run rate revenue and moves the Company into profitability. The higher margins of Australian Vaporizers are beneficial to the margins of the combined entity;
  • Provides full Australian distribution center and additional technical staff; and
  • Attractive valuation at approximately 1x sales and 5x EBITDA.

Transaction terms and conditions are as follows:

  • Purchase price of 1.0x 12-month trailing sales of $5.0 million, plus the value of inventory acquired within six (6) months preceding the closing, and 50% of the value of the inventory acquired prior to six (6) months preceding the closing, less all liabilities and plus trade debt and cash. The total purchase price is estimated to be approximately $5.5 million;
  • Consideration of 75% cash on closing, 10% in common shares based on the 20-day volume weighted average price upon signing of definitive agreement and 15% earn-out based on sales and integration milestones; and
  • Receipt of all director and requisite regulatory approvals relating to the transaction, including without limitation, CSE approval, if required.

Bought Deal Financing 

The Company is also pleased to announce that it has entered into a letter of engagement with Eight Capital and Canaccord Genuity Corp. as co-lead underwriters and joint bookrunners, and including Beacon Securities Limited. (together, the “Underwriters”), under which the Underwriters have agreed to purchase 24,000,000 units of the Company (the “Units”), on a “bought deal” private placement basis, subject to all required regulatory approvals, at a price per Unit of $0.25 (the “Offering Price”), for total gross proceeds of $6,000,000 (the “Offering”). Each Unit shall consist of one common share of the Company (a “Share”) and one-half of one common share purchase warrant (a “Warrant”). Each Warrant shall entitle the holder thereof to acquire one Share at a price of $0.35 for a period of 24 months following the Closing Date.

In the event that the closing sale price of the Company’s Shares on the Canadian Securities Exchange is greater than $0.70 per Share for a period of 10 consecutive trading days at any time after the closing of the Offering, the Company may accelerate the expiry date of the Warrants by giving notice to the holders thereof and in such case the Warrants will expire on the 30th day after the date on which such notice is given by the Company.

The Company has granted the Underwriters an over-allotment option to purchase up to an additional 3,600,000 Units at the Offering at the Offering Price, exercisable in whole or in part, at any time on or prior to 48 hours prior to the closing of the Offering. If this option is exercised in full, an additional $900,000 will be raised pursuant to the Offering and the aggregate proceeds of the Offering will be up to approximately $6,900,000.

The Company intends to use the net proceeds of the Offering will be used for the acquisition of Australian Vaporizers PTY Limited and for working capital and general corporate purposes.

The closing date of the Offering is scheduled to be on or about March 9, 2017 and is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the Canadian Securities Exchange and the applicable securities regulatory authorities.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.

Management Commentary  

Mr. Sean Dollinger, President and CEO of Namaste, comments: “The acquisition of Australian Vaporizers completes the geographical profile of Namaste and puts us in a very strong position in all four corners of the globe. This acquisition also further builds the critical mass of Namaste, instantly moves us into profitability and expands our database of high value customers. We look forward to further advancing our relationship with Australian Vaporizers and completing the proposed transaction.”

About Namaste Technologies Inc. 

Namaste Technologies Inc. is an emerging leader in vaporizer and accessories space. Namaste has 26 ecommerce retail stores in 20 countries, offers the largest range of brand name vaporizers products on the market and is actively manufacturing and launching multiple unique proprietary products for retail and wholesale distribution. The Company is currently focused on expanding its product offering, acquisitions and strategic partnerships, and entering new markets globally.

On behalf of the Board of Directors

Sean Dollinger

Chief Executive Officer

Further information on the Company and its products can be accessed through the links below:

www.namastetechnologies.com

www.namastevaporizers.com

www.namastevaporizers.co.uk

www.vaporseller.com

www.everyonedoesit.com

www.everyonedoesit.co.uk

FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

Namaste Technologies Inc.
Sean Dollinger
Chief Executive Officer
+1 (786) 389 9771
info@namastevapes.com
www.namastetechnologies.com

Durango Receives Offers On Windfall Gold Camp Property $DGO.ca

Posted by AGORACOM-JC at 8:59 AM on Friday, February 24th, 2017

Logo

  • Company receives two offers this week on its Trove Property located in the Windfall Lake (Urban Barry) district of northern Quebec
  • 100% wholly owned Trove Property adjoins Osisko Mining (TSX-OSK) in the Windfall-Urban gold camp where Osisko is drilling a 400,000 metre program
  • The Trove also adjoins Beaufield Resources (TSX.V-BFD) which holds multiple projects in the area and currently have drill programs underway.

Vancouver, BC / February 24, 2017 – Durango Resources Inc. (TSX.V-DGO), (the “Company” or “Durango”) announces for disclosure purposes that it has received two offers this week on its Trove Property located in the Windfall Lake (Urban Barry) district of northern Quebec.

Durango’s 100% wholly owned Trove Property adjoins Osisko Mining (TSX-OSK) in the Windfall-Urban gold camp where Osisko is drilling a 400,000 metre program. The Trove also adjoins Beaufield Resources (TSX.V-BFD) which holds multiple projects in the area and currently have drill programs underway.

Marcy Kiesman, CEO of Durango stated “Durango has held the Trove Project for years, and was initially interested in the area due to the favourable geology and the possibility of the regional gold discoveries being pervasive throughout the region. The Trove claims are strategically positioned along the faults and the recent interest of third parties confirms their increasing value. The Trove Property remains poised for discovery as the Windfall area has raised over $70 million this month for three companies in the area. The Board of Directors is reviewing the offers and will provide further details as they become available.”


Click Image To View Full Size

About Durango

Durango is a natural resources company engaged in the acquisition and exploration of mineral properties. The Company has a 100% interest in the Mayner’s Fortune and Smith Island limestone properties in northwest British Columbia, the Decouverte and Trove gold properties in the Abitibi Region of Quebec, and certain lithium properties near the Whabouchi mine, the Buckshot graphite property near the Miller Mine in Quebec, the Dianna Lake silver project in northern Saskatchewan, the Whitney Northwest property near the Lake Shore Gold and Goldcorp joint venture in Ontario, as well as three sets of claims in the Labrador nickel corridor.

For further information on Durango, please refer to its SEDAR profile at www.sedar.com.

Marcy Kiesman, Chief Executive Officer

Telephone: 604.428.2900 or 604.339.2243

Facsimile: 888.266.3983

Email: durangoresourcesinc@gmail.com

Website: www.durangoresourcesinc.com

Forward-Looking Statements

This document may contain or refer to forward-looking information based on current expectations, including, but not limited to the completion of a transaction involving the Trove Property with any third party and the impact on the Company of these events. Forward-looking information is subject to significant risks and uncertainties, as actual results may differ materially from forecasted results. Forward-looking information is provided as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances. For a detailed list of risks and uncertainties relating to Durango, please refer to the Company’s prospectus filed on its SEDAR profile at www.sedar.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

HPQ Silicon Annouces Closing of First Tranche of Over-Subscribed Private Placement $HPQ.ca

Posted by AGORACOM-JC at 4:10 PM on Thursday, February 23rd, 2017

Hpq large

  • Completed a first tranche closing of its previously announced non-brokered private placement consisting of the issuance and sale of an aggregate amount of 9,411,766 units at $0.17 per Unit for gross proceeds of $1,600,000
  • Net proceeds of the placement will be used for on-going R&D investments

MONTREAL, QUEBEC–(Feb. 23, 2017) - HPQ Silicon Resources Inc (“HPQ”) (TSX VENTURE:HPQ)(FRANKFURT:UGE)(OTC PINK:URAGD) is pleased to inform its shareholders that it has completed a first tranche closing of its previously announced non-brokered private placement consisting of the issuance and sale of an aggregate amount of 9,411,766 units (“Unit”) at $0.17 per Unit for gross proceeds of $1,600,000. The Net proceeds of the placement will be used for on-going R&D investments related to the development of 200 Ton/Year Solar Grade Silicon Metal PUREVAP™ Quartz Reduction Reactor Pilot equipment, general corporate expenses, legal expenses and placement fees.

Each Unit is comprised of one (1) common share and one (1) common share purchase warrant (“Warrant”) of the Company. Each Warrant will entitle the holder thereof to purchase one common share of the capital stock of the Company at an exercise price of $ 0.25 during a period of 24 months from the date of closing of the placement. Each share issued pursuant to the placement will have a mandatory four (4) month holding period from the date of closing of the placement. The placement is subject to standard regulatory approvals.

Bernard Tourillon, Chairman and CEO of HPQ Silicon stated: “Demand for participation in HPQ private placements continues to be strong, and once again we used the over allocation allotment mentioned in our February 3, 2017 press release to meet demand. These financings are key as they provide HPQ-Silicon the resources to continue the development of the Pilot Plant project with Pyrogenesis, as well as, the necessary time required for our discussions with Government based agencies that are managing funding programs for which the Company PUREVAP QRR is eligible for. ”

In connection with the placement the Company paid cash finder’s fee of $28,305 to Foster & Associates Financial Services Inc (“Foster”) of Toronto, Ontario and $23,100 to Redplug Capital Corp (“Redplug”) of Surrey, British Columbia. Furthermore the Company also issued 166,500 warrants to Foster and issued 136,000 warrants to Redplug. Each warrant, and any share purchased through the exercise of the warrants have the mandatory four (4) month holding period from the date of closing of the placement and gives Foster the right to purchase one (1) common share at 25.0 cents for 24 months and gives Redplug the right to purchase one (1) common share at 23.0 cents for 24 months.

OTHER CORPORATE MATTERS – Shares For Services Program

In accordance with the agreement between HPQ-Silicon and AGORACOM (see Uragold press release July 18, 2014), extended by both Parties for an additional year, from July 15, 2016 to July 15, 2017 under the same terms and conditions (previously disclose in HPQ September 16, 2016 press release), HPQ-Silicon Board has approved the issuance of 176,560 common shares at a deemed price of $0.16 per share for the outstanding debt of $28,250 for services rendered during the period from July 16, 2016 ending Jan 15, 2017.

About HPQ Silicon

HPQ Silicon Resources Inc is a TSX-V listed junior exploration company planning to become a vertically integrated and diversified High Value Silicon Metal (99.9+% Si), and Solar Grade Silicon Metal (99.999+% Si) producer.

Our business model is focused on developing a one step High Purity and Solar Grade Silicon Metal manufacturing process (patent pending) and becoming a vertically – integrated Solar Grade Silicon producer that can generate high yield returns and significant free cash flow within a relatively short time line.

Disclaimers:

This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or the securities laws of any state of the United States and may not be offered or sold within the United States or to, or for the account or the benefit of, U.S. persons (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Company’s current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company’s on-going filings with the securities regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Bernard J. Tourillon
Chairman and CEO
(514) 907-1011

Patrick Levasseur
President and COO
(514) 262-9239
www.HPQSilicon.com

Tetra Bio-Pharma Announces the Initiation of its Phase I Trial of dried Cannabis $TBP.ca

Posted by AGORACOM-JC at 8:45 AM on Thursday, February 23rd, 2017

Tbp large

  • Announces launch of its Double-Blind Phase I Study to Assess Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single and Multiple Daily Ascending Doses of Cannabis (Delta-9-tetrahydrocannabinol/ Cannabidiol) by Smoking/Inhalation in Healthy Male and Female Volunteers
  • Phase I clinical research is a classical pharmaceutical study in the development of a new drug. The trial activities will occur over a 3 to 4-month period and involve site initiation, subject recruitment and enrolment, a single daily ascending dose phase and a 7-day multiple daily ascending dose phase, followed by study termination

OTTAWA, ONTARIO–(Feb. 23, 2017) - PhytoPain Pharma (PPP), a subsidiary of Tetra BioPharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(CSE:TBP.CN)(OTC PINK:GRPOF), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain is pleased to announce the launch of its Double-Blind Phase I Study to Assess Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single and Multiple Daily Ascending Doses of Cannabis (Delta-9-tetrahydrocannabinol/ Cannabidiol) by Smoking/Inhalation in Healthy Male and Female Volunteers.

The Phase I clinical research is a classical pharmaceutical study in the development of a new drug. The trial activities will occur over a 3 to 4-month period and involve site initiation, subject recruitment and enrolment, a single daily ascending dose phase and a 7-day multiple daily ascending dose phase, followed by study termination. Algorithme Pharma has already begun recruiting subjects for the Phase I trial. This study is a pivotal safety trial as it will allow Tetra to understand the adverse effects of smoking Cannabis and associate the outcomes, such as cognitive function, to plasma levels of THC and CBD. The study will provide Tetra with the data necessary to discuss with Health Canada and FDA the potential risks in patient populations and discuss marketing requirements for specific indications.

The pharmacokinetic profile and safety data generated by the Phase I trial will allow Tetra to finalize the design of its Phase II-III clinical trial that will assess the safety and efficacy of PPP001 in cancer patients with uncontrolled pain. PPP001 is being developed for cancer patients with moderate-to-severe pain and that are not adequately controlled with the standard of care. Approximately 50% of cancer patients suffer from pain and more than 600,000 of these patients suffer from moderate-to-severe pain. In the USA, there are over 4 million cancer patients and this pain market is valued at over $5 billion USD.

We are very pleased to announce that the start of the Phase I clinical trial activities as this keeps the company on track in its development of PPP001″, commented Mr, Andre Rancourt. “With PPP001 and the mucoadhesive AdVersa® controlled-release tablet, Tetra is positioning itself to become a major player in the cancer pain therapy market, added Mr. Rancourt.

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Dr. Guy Chamberland
Chief Science Officer
(514) 220-9225

 

Fairmont (TSX-V: FMR) Receives Short Extension For Grabasa Acquisition $FMR.ca

Posted by AGORACOM-JC at 11:40 AM on Wednesday, February 22nd, 2017

  • Received an extension to complete the payment for Granitos de Badajoz  until March 8, 2017 from the Spanish Court in Badajo
  • “We have been working diligently with a European based funding group and they are in the final stages of completing the necessary documentation,” states Michael Dehn, President and CEO of Fairmont Resources…”

VANCOUVER, BRITISH COLUMBIA–(Feb. 22, 2017) – Fairmont Resources Inc. (“Fairmont”) (TSX VENTURE:FMR) is pleased to announce it has received an extension to complete the payment for Granitos de Badajoz (“Grabasa”) until March 8, 2017 from the Spanish Court in Badajoz.

“We have been working diligently with a European based funding group and they are in the final stages of completing the necessary documentation,” states Michael Dehn, President and CEO of Fairmont Resources. “While there can be no guarantee of success until this process is completed, this short extension was required to secure the Grabasa assets while finalizing the required logistics and paperwork for financing.”

Upon receipt of clearance documentation Fairmont will provide an update to all stakeholders, expected to be in less than a week, on the status of funding for Grabasa.

About Fairmont Resources Inc.

Fairmont Resources Inc. is a rapidly growing industrial mineral and dimensional stone company trading on the Toronto Venture Exchange symbol FMR.

Fairmont’s Quebec properties cover numerous occurrences of high-grade titaniferous magnetite with vanadium, with the Buttercup property having a permit to quarry dense aggregate. Where these occurrences have been tested they have display exceptional uniformity with respect to grade. Fairmont also controls three quartz/quartzite properties, with the Forestville property having independent end user testing confirming the suitability of quartzite from Forestville for Ferro Silicon production. Fairmont is also in the process of acquiring the assets of Granitos de Badajoz (GRABASA) in Spain which includes 23 quarries and a 40,000 square metre granite finishing facility that has produced finished granite installed across Europe.

On behalf of the Board of Directors,

Michael A. Dehn, President and CEO, Fairmont Resources Inc.

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Fairmont cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Fairmont’s control. Such factors include, among other things: risks and uncertainties relating to Fairmont’s ability to complete the proposed private placement financing, limited operating history and the need to comply with environmental and governmental regulations. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, Fairmont undertakes no obligation to publicly update or revise forward-looking information.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Michael A. Dehn
President and CEO, Fairmont Resources Inc.
647-477-2382
michael@fairmontresources.ca
www.fairmontresources.ca

Doren Quinton
President QIS Capital
250-377-1182
info@smallcaps.ca
www.smallcaps.ca

 

Chile’s SQM sees 8-10% growth in lithium demand this year $NAM.ca $DGO.ca $BFF.ca $SX.ca $FMR.ca

Posted by AGORACOM-JC at 11:22 AM on Wednesday, February 22nd, 2017
  • “The prices in the lithium market and the growth in demand have been quite relevant in recent years. We expect growth in demand for this product of between 8 and 10 percent,” Illanes said.

Feb 19 Chile’s SQM expects demand for lithium to grow between 8 percent and 10 percent this year and is working to improve financial performance by 2020, an executive told local paper El Mercurio on Sunday.

SQM, one of the world’s biggest producers of lithium and iodine, has been trying to consolidate its position with investments abroad.

In 2020 SQM expects annual earnings before interest, taxes, depreciation and amortization (EBITDA) of $1 billion. Currently quarterly EBITDA is less than $200 million, Gerardo Illanes, vice president of finances, told the newspaper.

“The prices in the lithium market and the growth in demand have been quite relevant in recent years. We expect growth in demand for this product of between 8 and 10 percent,” Illanes said.

SQM plans to invest $100 million to increase its production capacity this year, which combined with its capital injection in Argentina would lead to a total investment of around $300 million, he said.

Illanes said SQM would not have a problem financing its projects although he did not rule out tapping debt markets. (Reporting by Fabián Andrés Cambero; Writing by Caroline Stauffer; Editing by Jeffrey Benkoe)

Source: http://www.reuters.com/article/sqm-demand-idUSL1N1G407H